Evaluation of Safety of Levocetirizine in Routine Clinical Practice-non- Interventional Study

Completed

Conditions studied: Rhinitis Allergic, Persistent

In brief

To evaluate over a period of 6 months the safety and the treatment satisfaction of newly prescribed levocetirizine in patients of age ≥ 2 years with persistent allergic rhinitis.

Key facts

Study ID

NCT00598780

Run by

UCB Pharma

People needed

7870

Starts

2007-09-01

Expected to finish

2008-09-01

Last updated by the study team

2012-05-28

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• diagnosis of persistent allergic rhinitis
• first prescription of levocetirizine for this diagnosis for this patient
• age ≥ 2 years

You may not qualify if…

• indications other than those defined in inclusion criteria
• history of allergic or anaphylactic reactions to levocetirizine or other derivatives and excipients included

Where it is running

• UCB Pharma — Smyrna, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.